Suppression of plasma 6-keto-prostaglandin F1α and 13,14-dihydro-15-keto-prostaglandin F2α by aminoglutethimide in advanced breast cancer

This publication has 26 references indexed in Scilit:

• Measurement of 13,14-dihydro-15-keto-prostaglandin F2α an[6-keto-prostaglandin F1α in plasma by radioimmunoassay without prior extraction or chromatography
  Prostaglandins, Leukotrienes and Medicine, 1982
• Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
  BMJ, 1981
• Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids
  Nature, 1980
• The Direct Inhibition of Prostaglandin Synthetase of Human Breast Cancer Tumour Tissue by Tamoxifen
  Published by Springer Nature ,1980
• PRODUCTION OF PROSTAGLANDINS BY THE PSEUDOPREGNANT RAT UTERUS, in vitro, AND THE EFFECT OF TAMOXIFEN WITH THE IDENTIFICATION OF 6‐KETO‐PROSTAGLANDIN F_1α AS A MAJOR PRODUCT
  British Journal of Pharmacology, 1977
• BREAST-CANCER OSTEOLYSIS, BONE METASTASES, AND ANTI-OSTEOLYTIC EFFECT OF ASPIRIN
  The Lancet, 1976
• Is the sheep corpus luteum subject to tonic inhibition during the luteal phase of the estrous cycle?
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1976
• BREAST CANCER, PROSTAGLANDINS, AND BONE METASTASES
  The Lancet, 1975
• The effects of exogenous progesterone and estradiol on prostaglandin F levels in ovariectomized ewes
  Prostaglandins, 1972
• Evidence suggesting 11 β-hydroxylase inhibition during aminoglutethimide administration
  Metabolism, 1971